MediWound Ltd. logo

MediWound Ltd.

MDWD | NASDAQ
Chart Builder DCF Calculator
$13.31
-$0.09 (-0.67%)
At close: Sep 21, 2026, 4:00 PM ET
$13.52
+$0.21 (+1.58%)
Pre-market: Sep 22, 2026, 8:01 AM ET

Market Data

Market Cap
$170.98M
Enterprise Value
$145.17M
Beta
0.14
Average Volume
88.36K
Shares Outstanding (Diluted)
12.88M
Shares Change YoY
18.91%
Institutional Ownership
46.92%
Exchange
NASDAQ
ISIN
IL0011316309

Price Performance

Price Change 1M
0.3%
Price Change 3M
-5.4%
Price Change 6M
-21.6%
Price Change YTD
-27.7%
Price Change 1Y
-25.9%
Price Change 3Y
47.6%
Price Change 5Y
-45.5%
1M CAGR (ann.)
-7.5%
1Y CAGR (ann.)
-22.8%
5Y CAGR (ann.)
-12.7%
All-Time CAGR
-16.2%

Valuation

PE Ratio
-8.32
Forward PE
N/A
PEG Ratio
-0.23
Forward PEG
-26.81
PS Ratio
14.41
Forward PS
5.40
PB Ratio
4.80
P/FCF Ratio
-6.02
P/Adj. FCF Ratio
-5.62
P/OCF Ratio
-7.78
EV/Sales
12.24
EV/EBIT
-6.95
EV/EBITDA
-7.64
EV/FCF
-5.11
Earnings Yield
-12.0%
FCF Yield
-16.6%
Adj. FCF Yield
-17.8%

Financial Health

Net Cash
$34.41M
Total Debt
$9.54M
Cash & Short-Term Investments
$35.34M
Total Assets
$71.88M
Current Ratio
2.32
Quick Ratio
2.09
Debt / Equity Ratio
0.27
Debt / EBITDA
-0.50
Debt / FCF
-0.34
OCF / Debt
-2.31
Interest Coverage
-28.35
Altman Z-Score
-1.31
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
15.5%
Operating Profit Margin
-267.9%
EBITDA Margin
-160.2%
Net Profit Margin
-170.1%
FCF Margin
-239.3%
Adj. FCF Margin
-256.5%
SBC / Revenue
17.3%
SBC Impact (per share)
-7.2%

Returns

Return on Assets
-28.1%
Return on Equity
-47.2%
Return on Invested Capital
-58.5%
Return on Capital Employed
-59.6%
Return on Tangible Assets
-28.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-23.0%
Revenue CAGR 5Y
-14.0%
Revenue CAGR 10Y
28.3%
EPS CAGR 3Y
13.1%
EPS CAGR 5Y
15.8%
EPS CAGR 10Y
6.2%
FCF CAGR 3Y
-14.6%
FCF CAGR 5Y
-19.2%
FCF CAGR 10Y
-11.8%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
13
EPS Growth Next 3Y
44.4%
Revenue Growth Next 3Y
109.9%
Earnings Date
Nov 18, 2026
EPS Estimate (next Q)
-$0.71
EPS Growth Est (next Q)
194.7%
Revenue Est (next Q)
$6.73M
Revenue Growth Est (next Q)
23.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$28.50
Price Target Upside
114.1%

Cash Flow

Operating Cash Flow
$-22M
Free Cash Flow
$-28.39M
Adj. Free Cash Flow
$-30.43M
FCF Per Share
-$2.20
OCF Per Share
-$1.71
OCF/S Ratio
-185.5%

Income Statement

Revenue
$11.86M
Gross Profit
$1.83M
Operating Income
$-31.78M
EBITDA
$-19M
Net Income
$-20.18M
EPS (Diluted)
-$1.60
Revenue / Employee
$98.04K
Profit / Employee
$-166.77K
Employees
121

© 2026 bestshares.com. All rights reserved.